Updates from FDA’s Office of Prescription Drug Promotion: Standards for Direct-to-Consumer Advertising Read more
Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open Payments Reporting for 2023, Impact of Life Science Compliance, HHS-OIG revision of compliance guidance, and US Final Regulation for Drug Price Negotiations Read more
Policy and Medicine Compliance Update May 2023 Issue Features: Regulatory Challenges in Diversity in Clinical Trials, Embracing Generative Artificial Intelligence, Novo Nordisk’s Trans-Atlantic Speech Woes, and The Sixth Circuit Tackles the Meaning of Remuneration in Kickback Cases Read more